10.1002/ejoc.201900648
European Journal of Organic Chemistry
FULL PAPER
General procedure for the synthesis of the compounds 14h–j. N-Boc
protected amine 3 (0.10 mol) was dissolved in dioxane (100 mL), and 4
M solution of HCl in dioxane (250 mL) was added. The reaction mixture
was stirred for 2 h, and the solvent was rotary evaporated. The residue
was triturated with Et2O (150 mL), the precipitate was filtered off and
dried under vacuum.
– 3.55 (m, 0.5H), 3.52 – 3.41 (m, 1H), 3.37 (t, J = 8.3 Hz, 0.5H), 3.28 –
3.14 (m, 1H), 2.78 (dt, J = 17.0, 9.8 Hz, 1H), 2.32 – 2.20 (m, 1H), 2.02 –
1.94 (m, 1H), 1.49 – 1.43 (m, 1H), 1.43 (s, 9H), 1.25 – 1.20 (m, 12H),
0.93 – 0.79 (m, 2H) ppm. 13C NMR (126 MHz, cdcl3) δ 154.6, 83.1, 78.7,
53.4 and 52.8, 45.8 and 45.5, 35.0 and 34.2, 34.1 and 33.2, 28.5, 24.8,
15.0 ppm. MS (APCI): m/z = 211 [M–C(O)OC(CH3)3+H]+. Anal. Calcd. for
C16H30BNO4: C 61.75; H 9.72; N 4.50. Found: C 62.12; H 10.11; N 4.58.
3-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-
yl)methylene)pyrrolidine hydrochloride (14h). Yield 17.2 g (97%) from
tert-Butyl
3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)-
22.3
g
of tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
piperidine-1-carboxylate (15i). Yield: 39.6 g (91%) from 43.2 g of (Z)-
tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)pipe-
ridine-1-carboxylate (3i); yellow oil. 1H NMR (400 MHz, CDCl3) δ 3.93 (d,
J = 12.1 Hz, 2H), 2.61 (t, J = 12.6 Hz, 1H), 2.34 (t, J = 11.7 Hz, 1H), 1.79
(d, J = 13.1 Hz, 1H), 1.65 – 1.51 (m, 2H), 1.41 (s, 9H), 1.38 – 1.33 (m,
1H), 1.21 (s, 12H), 1.09 – 0.95 (m, 1H), 0.74 – 0.58 (m, 2H) ppm. 13C
NMR (101 MHz, CDCl3) δ 154.9, 83.2, 79.1, 51.9, 43.8, 33.5, 32.5, 28.6,
25.4, 24.9, 16.5 ppm. MS (APCI): m/z = 225 [M–C(O)OC(CH3)3+H]+. Anal.
Calcd. for C17H32BNO4: C 62.78; H 9.92; N 4.31. Found: C 62.55; H 9.70;
N 4.03.
yl)methylene)pyrrolidine-1-carboxylate (3h); yellow solid, mp 155–157 °C.
The compound was obtained as ca. 1:1 mixture of E/Z isomers. H NMR
1
(400 MHz, CDCl3) δ 9.94 (br s, 2H), 5.46 (s, 1H), 5.40 (t, J = 2.3 Hz, 1H),
4.09 (s, 0.5H), 3.91 (s, 0.5H), 3.49 – 3.39 (m, 1H), 3.39 – 3.32 (m, 1H),
2.94 (t, J = 7.7 Hz, 1H), 2.76 (t, J = 7.5 Hz, 1H), 1.20 (s, 12H) ppm. 13C
NMR (126 MHz, CDCl3) δ 155.9 and 155.4, 113.6 and 113.2, 83.7 and
83.4, 50.3 and 48.7, 45.9 and 44.8, 33.4 and 30.4, 24.9 ppm. MS (EI):
m/z = 209 [M–HCl]+, 194 [M–HCl–CH3]+. Anal. Calcd. for C11H21BClNO2:
C 53.81; H 8.62; N 5.70; Cl 14.44. Found: C 54.01; H 8.47; N 5.93; Cl
14.08.
tert-Butyl
4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)-
(Z)-3-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-
piperidine-1-carboxylate (15j).[47] Yield: 42.3 g (90%) from 46.7 g of
yl)methylene)piperidine hydrochloride (14i). Yield 19.9 g (97%) from
tert-butyl
4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-
1
25.6
g
of (Z)-tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
piperidine-1-carboxylate (3j); colourless oil. H NMR (400 MHz, CDCl3) δ
4.01 (s, 2H), 2.67 (t, J = 12.1 Hz, 2H), 1.67 – 1.57 (m, 3H), 1.43 (s, 9H),
1.22 (s, 12H), 1.17 – 1.01 (m, 2H), 0.75 (d, J = 6.7 Hz, 2H) ppm. 13C
NMR (101 MHz, CDCl3) δ 155.0, 83.1, 79.2, 44.2, 34.6, 32.5, 28.6, 25.0,
19.4 ppm. MS (EI): m/z = 325 [M]+. Anal. Calcd. for C17H32BNO4: C
62.78; H 9.92; N 4.31. Found: C 62.86; H 10.14; N 4.29.
yl)methylene)piperidine-1-carboxylate (3i); colourless solid, mp 230–
232 °C. 1H NMR (400 MHz, DMSO-d6) δ 9.44 (br s, 2H), 5.30 (s, 1H),
3.87 (s, 2H), 3.11 – 3.02 (m, 2H), 2.36 (t, J = 6.4 Hz, 2H), 1.84 – 1.72 (m,
2H), 1.22 (s, 12H) ppm. 13C NMR (126 MHz, DMSO-d6) δ 153.1, 117.6,
83.1, 45.7, 42.5, 34.3, 24.6, 23.0 ppm. MS (EI): m/z = 223 [M–HCl]+, 208
[M–HCl–CH3]+. Anal. Calcd. for C12H23BClNO2: C 55.53; H 8.93; N 5.40;
Cl 13.66. Found: C 55.64; H 9.17; N 5.22; Cl 13.81.
Methyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)cyclo-
butanecarboxylate (17d). Yield: 37.8 g (91%) from 41.2 g of methyl 3-
((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclobutane-
carboxylate (3d); colourless liquid. The compound was obtained as ca.
25:75 mixture of E/Z stereoisomers. 1H NMR (400 MHz, CDCl3) δ 3.65 (s,
0.75H) and 3.62 (s, 2.25H), 3.12 – 3.02 (m, 0.25H) and 2.89 (quint, J =
9.2 Hz, 0.75H), 2.61 – 2.52 (m, 0.25H) and 2.45 – 2.37 (m, 0.75H), 2.36
– 2.26 (m, 2H), 1.92 – 1.79 (m, 2H), 1.20 (s, 12H), 0.98 (d, J = 7.9 Hz,
0.5H) and 0.92 (d, J = 6.9 Hz, 1.5H) ppm. 13C NMR (126 MHz, CDCl3) δ
176.9 and 175.8, 83.1 and 82.9, 51.7 and 51.6, 34.7 and 34.5, 34.0 and
32.8, 28.6 and 28.3, 24.9, 19.4 ppm. MS (EI): m/z = 254 [M]+. Anal. Calcd.
for C13H23BO4: C 61.44; H 9.12. Found: C 61.78; H 8.85.
4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)piperidine
hydrochloride (14j). Yield 23.8 g (97%) from 31.2 g of tert-butyl 4-
((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)piperidine-1-
carboxylate (3j); colourless solid, mp 180–182 °C. 1H NMR (400 MHz,
CDCl3) δ 9.66 (br s, 2H), 5.20 (s, 1H), 3.25 – 3.15 (m, 4H), 2.95 (t, J =
6.0 Hz, 2H), 2.58 (t, J = 5.9 Hz, 2H), 1.20 (s, 12H) ppm. 13C NMR (126
MHz, CDCl3) δ 154.8, 116.3, 83.2, 45.3, 45.2, 35.1, 28.9, 24.9 ppm. MS
(APCI): m/z = 224 [M–Cl]+. Anal. Calcd. for C12H23BClNO2: C 55.53; H
8.93; N 5.40; Cl 13.66. Found: C 55.13; H 9.05; N 5.76; Cl 13.70.
General procedure for the synthesis of the compounds 15g–j and
17d,e. Alkene 3 (0.10 mol) was dissolved in THF (100 mL), and 10% Pd–
C (1.5 g) was added. The flask was evacuated, backfilled with hydrogen
gas from a balloon and left to stir overnight at rt.The reaction mixture was
filtered, and the solvent was rotary evaporated.
Ethyl
3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)cyclo-
pentanecarboxylate (17e). Yield: 25.4 g (99%) from 25.5 g of (Z)-ethyl
3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methylene)cyclopentanecarboxylate (3e); yellow liquid. The compound
was obtained as a mixture of diastereomers. 1H NMR (400 MHz, CDCl3)
δ 4.00 (q, J = 7.1 Hz, 2H), 3.67 – 3.57 (m, 1H), 2.75 – 2.57 (m, 1H), 2.09
– 1.97 (m, 1H), 1.96 – 1.86 (m, 1H), 1.86 – 1.60 (m, 4H), 1.13 (s, 15H),
0.81 – 0.70 (m, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 176.6, 82.9, 67.9
and 60.0, 43.8 and 43.0, 39.3 and 38.2, 36.7 and 35.4, 35.1 and 34.3,
29.7 and 28.9, 25.6 and 24.8, 17.2, 14.2 ppm. 11B NMR (160 MHz,
CDCl3): δ 33.6 ppm. MS (EI): m/z = 282 [M]+. Anal. Calcd. for C15H27BO4:
C 63.85; H 9.64. Found: C 64.20; H 9.50.
tert-Butyl
3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)-
azetidine-1-carboxylate (15g).[46] Yield: 40.4 g (90%) from 44.6 g of tert-
butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)azetidine-
1
1-carboxylate (3g); colourless oil. H NMR (400 MHz, CDCl3) δ 3.98 (t, J
= 8.3 Hz, 2H), 3.47 (dd, J = 8.5, 5.7 Hz, 2H), 2.70 – 2.57 (m, 1H), 1.38 (s,
9H), 1.18 (s, 12H), 1.05 (d, J = 7.9 Hz, 2H) ppm. 13C NMR (101 MHz,
CDCl3) δ 156.5, 83.3, 79.0, 56.6, 28.5, 25.3, 24.9, 17.0 ppm. MS (EI):
m/z = 297 [M]+. Anal. Calcd. for C15H28BNO4: C 60.62; H 9.50; N 4.71.
Found: C 60.96; H 9.81; N 4.96.
3-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)azetidine
2,2,2-trifluoroacetate (16g). tert-Butyl 3-((4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)methyl)azetidine-1-carboxylate (15g) (39.5 g, 0.133
mol) was dissolved in CH2Cl2 (40 mL), and CF3COOH (40 mL) was
added. The reaction mixture was stirred for 2 h and the solvent was
evaporated under reduced pressure. The residue was dissolved in H2O
(200 mL) and the aqueous phase was washed with CH2Cl2 (2×250 mL).
The aqueous phase was concentrated under reduced pressure and dried
tert-Butyl
pyrrolidine-1-carboxylate (15h). Yield: 25.3 g (85%) from 29.6 g of tert-
butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)-
yl)methylene)pyrrolidine-1-carboxylate (3h); yellow oil. The compound
existed as ca. 1:1 mixture of rotamers.1H NMR (500 MHz, CDCl3) δ 3.62
This article is protected by copyright. All rights reserved.